Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
UNKNOWN
NCT00677313
Expanded Access for Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
This is an expanded access designed to provide metreleptin for the treatment of diabetes mellitus and/or hypertriglyceridemia associated with lipodystrophy.
Key Details
Gender
Not specified
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-08-21
Healthy Volunteers
Not specified
Interventions
DRUG
metreleptin
metreleptin